A detailed history of Peak6 Investments LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Peak6 Investments LLC holds 10,000 shares of CRNX stock, worth $539,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 8,000 25.0%
Holding current value
$539,400
Previous $358,000 42.46%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$43.83 - $54.98 $87,660 - $109,960
2,000 Added 25.0%
10,000 $510,000
Q2 2024

Aug 13, 2024

BUY
$42.12 - $51.91 $336,960 - $415,280
8,000 New
8,000 $358,000

Others Institutions Holding CRNX

About Crinetics Pharmaceuticals, Inc.


  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.9B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.